SCHEMBL25545935

SCHEMBL25545935

COc1cc(-c2nc(Cl)sc2CCC(C)C)ccc1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PAX8 Q06710 1/20 0.38
PIK3CD O00329 1/20 0.38
ABL1 P00519 1/20 0.38
EGFR P00533 1/20 0.38
HCK P08631 1/20 0.38
SRC P12931 1/20 0.38
KDR P35968 1/20 0.38
PIK3CA P42336 1/20 0.38
PIK3CB P42338 1/20 0.38
MTOR P42345 1/20 0.38
PIK3CG P48736 1/20 0.38
EPHB4 P54760 1/20 0.38
PRKDC P78527 1/20 0.38
PI4KB Q9UBF8 1/20 0.38
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
SLC10A2 Q12908 1/20 0.36
AAK1 Q2M2I8 2/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25545930 0.91 ALDH1A1 (0.41) LMNAMAPTSLC10A2AAK1MEN1
SCHEMBL25545938 0.88 DYRK1A (0.39) LMNAMAPTSLC10A2AAK1MEN1
SCHEMBL25545928 0.88 FBP1 (0.42) PAX8PIK3CDABL1EGFRHCK
SCHEMBL25546022 0.88 TRPV1 (0.35) PIK3CDABL1EGFRHCKSRC
SCHEMBL25546328 0.87 S1PR1 (0.43) LMNAMAPTSLC10A2AAK1MEN1
SCHEMBL25545956 0.86 GRM2 (0.39) LMNAMAPTSLC10A2MEN1KMT2A
SCHEMBL25545547 0.81 AAK1 (0.36) AAK1ALDH1A1HTT
SCHEMBL25545936 0.81 PAX8 (0.39) PAX8PIK3CDABL1EGFRHCK
SCHEMBL25545925 0.79 ALDH1A1 (0.42) LMNAMAPTAAK1MEN1KMT2A
SCHEMBL25545941 0.77 LMNA (0.48) LMNAMAPTMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230150997-A1 EIF4E INHIBITORS AND USES THEREOF PIC Therapeutics, Inc. 2023-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150997-A1 EIF4E INHIBITORS AND USES THEREOF EIF4E, EIF4EBP1, EIF4A1 PAX8 2117/4885PIK3CD 1130/4885ABL1 888/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.